Dr Reddys received comments from USFDA, weakening the stock

equity service

US drug regulator USFDA has given 11 drops to Dr Reddys, the leading pharmaceutical company, for its formulation plants located in Hyderabad.

USFDA has issued comments after Dr Reddy’s inspection of this plant But the drug company has not provided the inspection date. 

According to the rules, the company has been awarded Form 483 with 11 comments. Explain that the company receiving the comments from USFDA has to reply in writing in 15 days with corrective and preventive action plan. 

Due to this news, the shares of Dr. Reddy’s are under pressure today. In the BSE, Dr Reddy’s shares are open at Rs 2,670.00 with weakness compared to the previous closed level of Rs 2,772.30. At around 10 o’clock in the morning, it is at Rs. 2686.85 with a gain of Rs. 85.45 or 3.08%. In the last 52 weeks, the company’s share went up to Rs 2,875.00, while the bottom slipped to Rs 1,888.00.

Get detailed equity Service provider right here at BSE & NSE. We provide Indian Stock market service like Equity Service, MCX, HNI& Currency Service | Ripples Advisory Private Limited

Please follow and like us:
20